Chemistry: natural resins or derivatives; peptides or proteins; – Proteins – i.e. – more than 100 amino acid residues
Reexamination Certificate
2005-08-26
2009-11-03
Parkin, Jeffrey S. (Department: 1648)
Chemistry: natural resins or derivatives; peptides or proteins;
Proteins, i.e., more than 100 amino acid residues
C424S185100, C424S188100, C424S208100, C530S324000, C530S325000, C530S326000, C530S327000, C530S328000, C530S329000
Reexamination Certificate
active
07612168
ABSTRACT:
The present invention comprises novel and modified peptides capable of inducing a HIV-1 specific immune response without antagonizing the cytotoxic T-cell activity in order to achieve an effective prophylactic and therapeutic vaccine against HIV. The peptides are based on conserved regions of HIV gag p17 and p24 proteins. Antigens in free- or carrier-bound form comprising at least one of the said peptides, vaccine compositions containing at least one of the antigens, immunoassay kits and a method of detecting antibodies induced by HIV or HIV specific peptides using such antigens, are described.
REFERENCES:
patent: 5972339 (1999-10-01), Walker
patent: 6706859 (2004-03-01), Sorensen
patent: 0732339 (1996-09-01), None
patent: 2236754 (1991-04-01), None
patent: 9837089 (1989-08-01), None
patent: 91/13360 (1991-09-01), None
patent: 92/22572 (1992-12-01), None
patent: 98/29551 (1998-07-01), None
patent: 9958658 (1999-11-01), None
patent: 00/52040 (2000-09-01), None
Phillips, et al., “Human immunodeficiency virus genetic variation that can escape cytotoxic T cell recognition,” Nature, vol. 354, Dec. 1991, pp. 453-459.
Klenerman, et al., “Cytotoxic T-cell activity antagonized by naturally occurring HIV-1 Gag variants,” Nature, vol. 369, No. 6479, Jun. 1994, pp. 403-407.
Goulder, et al., “Differential Narrow Focusing of Immunodominant Human Immunodeficiency Virus Gag-Specific Cytotoxic T-Lymphocyte Responses in Infected African and Caucasoid Adults and Children,” Journal of Virology, vol. 74, No. 12, Jun. 2000, pp. 5679-5690.
Mathiesen, et al., “Mapping of IgG subclass and T-cell epitopes on HIV proteins by synthetic peptides,” Immunology, vol. 67, No. 4, 1989, pp. 453-459.
Truong et al., “Comparison of antibody responses to different forms of HIV-1 core antigens by epitope mapping”,J. Medical Virology, vol. 51, pp. 145-151, 1997.
Chong et al.Int. J. Peptide Protein Res., vol. 41, pp. 21-27, 1992.
Ruan et al., “The Drosophila Insulin Receptor Contains a Novel Carboxyl-terminal Extension Likely to Play an Important Role in Signal Transduction”,Journal of Biological Chemistry, vol. 270, No. 9, pp. 4236-4243, 1995.
Riffkin et al., AA single amino-acid change between the antigenically different extracellular serine proteases V2 and B2 from Dichelobacter nodosus@,Gene, vol. 167, pp. 279-283, 1995.
Abaza et al., A Effects of amino acid substitutions outside an antigenic site on protein binding to monoclonal antibodies of predetermined specificity obtained by peptide immunization@,Journal of Protein Chemistry, vol. 11, No. 5, pp. 433-444, 1992.
Cruse et al.,Illustrated Dictionary of Immunology, (Boca Raton, FL, CRC Press, Inc., 1995), p. 309. QR180.4.C78.
Paul,Fundamental Immunology, (Philadelphia & New York, Lippincott-Raven Publishers, 1993), pp. 250 and pp. 1311-1312. QR181.F84.
Cohen et al., A Pronounced acute immunosuppression in vivo medicated by HIV Tat challenge@,Proceedings of the National Academy of Sciences of the United States of America, vol. 96, Issue 19, pp. 10842-10847, 1999.
Bionor Immuno As
Humphrey Louise
Parkin Jeffrey S.
Wenderoth , Lind & Ponack, L.L.P.
LandOfFree
Modified HIV peptides, antigens, compositions, immunoassay... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Modified HIV peptides, antigens, compositions, immunoassay..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Modified HIV peptides, antigens, compositions, immunoassay... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4076878